通过专为投资者打造的一站式数据看板，全面查看 SAB Biotherapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

256.14M

股息TTM

0.00

市盈率 TTM

7.83

每股收益TTM

0.43

营业收入

0.00

净利润

-34.11M

净资产收益率

-7.57%

总资产收益率

-0.28%

SAB Biotherapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

74.08%-0.28

37.01%-0.35

95.17%-0.06

144.80%0.50

-37.30%-1.09

-2.85%-0.56

63.73%-1.23

-14.80%-1.12

41.92%-0.79

62.73%-0.54

-93.08%-3.38

---0.97

---1.36

---1.46

---1.75

---2.52

----

营业收入

----

-100.00%0.00

--0.00

-100.00%0.00

-62.40%114.70K

-100.00%0.00

207.70%263.14K

62.55%944.58K

-85.88%305.01K

-64.69%1.27M

-98.65%85.52K

-95.08%581.10K

-96.45%2.16M

--3.59M

--6.35M

--11.80M

--60.88M

----

净利润

-122.37%-22.49M

-263.09%-18.87M

75.03%-2.85M

151.57%5.34M

-37.88%-10.11M

-3.40%-5.20M

50.15%-11.39M

-102.84%-10.35M

-6.61%-7.34M

31.66%-5.03M

-190.26%-22.86M

27.89%-5.10M

-44.07%-6.88M

-845.93%-7.35M

55.22%-7.87M

-2038.89%-7.08M

-116.88%-4.78M

-66.84%985.86K

---17.58M

---330.83K

利润率

----

-32.57%-9934.52%

----

65.35%-2787.69%

57.96%-532.06%

-1956.36%-7493.75%

---402.59%

---8046.13%

---1265.50%

---364.42%

---49.97%

----

毛利率

----

0.00%100.00%

----

0.00%100.00%

--100.00%

----

资产负债率

-87.91%1.34%

-85.89%1.30%

-77.32%1.90%

-71.86%1.81%

67.71%11.11%

51.47%9.24%

52.49%8.36%

-55.90%6.42%

-44.95%6.63%

-44.79%6.10%

-45.04%5.48%

--14.55%

--12.04%

--11.05%

--9.97%

--7.29%

----

利润表

营业收入

----

-100.00%0.00

--0.00

-100.00%0.00

-62.40%114.70K

-100.00%0.00

207.70%263.14K

62.55%944.58K

-85.88%305.01K

-64.69%1.27M

-98.65%85.52K

-95.08%581.10K

-96.45%2.16M

--3.59M

--6.35M

--11.80M

--60.88M

----

营业利润

-141.18%-23.32M

-86.20%-19.93M

-57.56%-15.77M

-12.24%-12.61M

4.58%-9.67M

5.44%-10.71M

46.97%-10.01M

-113.96%-11.24M

-58.15%-10.13M

-54.41%-11.32M

-140.12%-18.87M

32.10%-5.25M

1.02%-6.41M

-10.51%-7.33M

38.06%-7.86M

-2205.55%-7.74M

-2419.77%-6.47M

-5845.01%-6.64M

---12.69M

---335.55K

净利润

-122.37%-22.49M

-263.09%-18.87M

75.03%-2.85M

151.57%5.34M

-37.88%-10.11M

-3.40%-5.20M

50.15%-11.39M

-102.84%-10.35M

-6.61%-7.34M

31.66%-5.03M

-190.26%-22.86M

27.89%-5.10M

-44.07%-6.88M

-845.93%-7.35M

55.22%-7.87M

-2038.89%-7.08M

-116.88%-4.78M

-66.84%985.86K

---17.58M

---330.83K

资产负债表

流动资产

1059.60%107.94M

592.05%112.78M

324.73%101.05M

248.15%113.28M

-76.48%9.31M

-65.29%16.30M

-59.61%23.79M

940.28%32.54M

339.48%39.58M

212.34%46.95M

166.58%58.91M

-85.90%3.13M

-67.55%9.01M

-58.44%15.03M

-55.97%22.10M

2778.49%22.18M

2862.68%27.75M

3127.60%36.17M

--50.19M

--770.62K

流动负债总额

9.62%11.71M

2.06%9.85M

33.86%10.68M

22.43%10.79M

41.38%10.68M

16.24%9.65M

-26.21%7.98M

-4.29%8.82M

-31.41%7.55M

-39.23%8.30M

-27.88%10.81M

-46.14%9.21M

-31.77%11.01M

-25.14%13.67M

-43.33%14.99M

5204.75%17.10M

10455.55%16.14M

22719.85%18.26M

--26.46M

--322.38K

总资产

690.62%238.21M

551.81%248.47M

291.01%172.81M

241.00%183.45M

-51.32%30.13M

-46.59%38.12M

-47.35%44.20M

89.85%53.80M

74.63%61.89M

67.26%71.37M

64.90%83.94M

-46.03%28.34M

-40.09%35.44M

-36.76%42.67M

-37.26%50.90M

-55.09%52.51M

-49.48%59.15M

-42.47%67.47M

--81.14M

--116.93M

总负债

29.33%23.43M

26.98%21.22M

16.95%21.32M

8.76%18.37M

14.84%18.11M

-9.90%16.71M

-31.59%18.23M

29.16%16.89M

0.29%15.77M

1.53%18.55M

34.24%26.64M

-40.23%13.08M

-28.63%15.73M

-30.31%18.27M

-53.40%19.85M

117.27%21.88M

122.46%22.03M

232.52%26.21M

--42.59M

--10.07M

总权益

1687.46%214.78M

961.54%227.25M

483.35%151.49M

347.32%165.07M

-73.95%12.02M

-59.47%21.41M

-54.68%25.97M

141.89%36.90M

133.92%46.12M

116.46%52.82M

84.49%57.30M

-50.18%15.26M

-46.89%19.72M

-40.85%24.40M

-19.43%31.06M

-71.34%30.62M

-65.37%37.12M

-62.28%41.26M

--38.55M

--106.86M

现金流量表

经营净额

-37.60%-9.84M

-83.03%-14.27M

-76.00%-16.78M

-107.41%-13.05M

7.34%-7.15M

27.47%-7.80M

29.11%-9.53M

-21.75%-6.29M

-57.53%-7.72M

-569.48%-10.75M

-6304.59%-13.45M

19.28%-5.17M

5.95%-4.90M

83.16%-1.61M

-91.47%216.72K

-7098.79%-6.40M

-5044.68%-5.21M

-2526.32%-9.54M

--2.54M

---88.93K

投资净额

-193.95%-4.88M

-1505.40%-65.65M

-118.29%-1.71M

-11167.05%-129.87M

-53.67%5.20M

114.90%4.67M

13849.21%9.33M

-2721.23%-1.15M

49556.96%11.22M

-147126.32%-31.36M

42.37%-67.86K

47.96%-40.86K

96.30%-22.68K

98.34%-21.30K

-100.11%-117.75K

---78.50K

---612.83K

98.90%-1.28M

--105.21M

--0.00

融资净额

1459.77%2.36M

51783.26%89.92M

-119.21%-41.69K

25123.21%168.69M

45.85%-173.84K

55.89%-173.99K

-99.68%216.96K

-380.46%-674.13K

11.75%-321.04K

-9.62%-394.42K

922.37%67.64M

92.22%-140.31K

-1312.30%-363.79K

94.31%-359.79K

108.13%6.62M

---1.80M

--30.01K

-105.39%-6.32M

---81.39M

--0.00

常见问题

SAB Biotherapeutics Inc的流动资产是多少？



根据SAB Biotherapeutics Inc的FY2025财报，流动资产为101.05M（同比变化324.73）。

SAB Biotherapeutics Inc的总资产是多少？



根据SAB Biotherapeutics Inc的FY2025财报，SAB Biotherapeutics Inc的总资产为172.81M（同比变化291.01）。

SAB Biotherapeutics Inc的总负债是多少？



根据SAB Biotherapeutics Inc的FY2025财报，SAB Biotherapeutics Inc的总负债为21.32M（同比变化16.95）。

SAB Biotherapeutics Inc的总权益是多少？



根据SAB Biotherapeutics Inc的FY2025财报，SAB Biotherapeutics Inc的总权益为151.49M（同比变化483.35）。

SAB Biotherapeutics Inc的净营业收入是多少？



根据SAB Biotherapeutics Inc的FY2025财报，SAB Biotherapeutics Inc的净营业收入为-48.85M（同比变化-14.12）。

SAB Biotherapeutics Inc的净投资是多少？



根据SAB Biotherapeutics Inc的FY2025财报，SAB Biotherapeutics Inc的净投资为-121.71M（同比变化-917.42）。

SAB Biotherapeutics Inc的净融资是多少？



根据SAB Biotherapeutics Inc的FY2025财报，SAB Biotherapeutics Inc的净融资为168.30M（同比变化14452.36）。

SAB Biotherapeutics Inc的每股收益（EPS）是多少？



根据SAB Biotherapeutics Inc的FY2025财报，每股收益（EPS）为0.22（同比变化105.99）。

SAB Biotherapeutics Inc的净利润是多少？



根据SAB Biotherapeutics Inc的FY2025财报，净利润为4.26M（同比变化112.49）。

SAB Biotherapeutics Inc的债务与资产比率是多少？



根据SAB Biotherapeutics Inc的FY2025财报，债务与资产比率为1.90（同比变化-77.32）。

SAB Biotherapeutics Inc的股东权益回报率（ROE）是多少？



根据SAB Biotherapeutics Inc的FY2025财报，股东权益回报率（ROE）为4.80（同比变化105.86）。

SAB Biotherapeutics Inc的资产回报率（ROA）是多少？



根据SAB Biotherapeutics Inc的FY2025财报，资产回报率（ROA）为12.23（同比变化122.98）。

SAB Biotherapeutics Inc的营业利润是多少？



根据SAB Biotherapeutics Inc的FY2025财报，营业利润为-48.85M（同比变化-14.12）。